Review



rabbit anti-human capg polyclonal antibodies  (Proteintech)


Bioz Verified Symbol Proteintech is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Proteintech rabbit anti-human capg polyclonal antibodies
    Rabbit Anti Human Capg Polyclonal Antibodies, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-human capg polyclonal antibodies/product/Proteintech
    Average 90 stars, based on 1 article reviews
    rabbit anti-human capg polyclonal antibodies - by Bioz Stars, 2026-02
    90/100 stars

    Images



    Similar Products

    90
    Sino Biological 14213 t52
    14213 T52, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/14213 t52/product/Sino Biological
    Average 90 stars, based on 1 article reviews
    14213 t52 - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    90
    Proteintech rabbit anti-human capg polyclonal antibodies
    Rabbit Anti Human Capg Polyclonal Antibodies, supplied by Proteintech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-human capg polyclonal antibodies/product/Proteintech
    Average 90 stars, based on 1 article reviews
    rabbit anti-human capg polyclonal antibodies - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    93
    Proteintech rabbit anti capg

    Rabbit Anti Capg, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti capg/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti capg - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    93
    Proteintech rabbit anti capg proteintech

    Rabbit Anti Capg Proteintech, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti capg proteintech/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit anti capg proteintech - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    86
    Danaher Inc rabbit anti capg polyclonal antibody

    Rabbit Anti Capg Polyclonal Antibody, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti capg polyclonal antibody/product/Danaher Inc
    Average 86 stars, based on 1 article reviews
    rabbit anti capg polyclonal antibody - by Bioz Stars, 2026-02
    86/100 stars
      Buy from Supplier

    93
    Proteintech rabbit polyclonal anti capg antibody
    Suppression of <t>CAPG</t> impairs EBOV infection. ( A ) CAPG knockdown (KD) was confirmed by immunoblot assay. Four siRNA targeting different regions of human CAPG were transfected into Hela cells at 40 nM. After 48 h, cells were challenged with virus and a replicate set were lysed for protein expression analysis by immunoblot (a representative blot is shown). β-actin was used as a loading control. Band intensity from triplicate samples was calculated using ImageJ, and normalized to the β-actin loading control. ( B ) Yield of infectious particles in the supernatant was measured by counting GP positive foci on VeroE6 cells. Cells were inoculated with the supernatant from wild-type EBOV-infected cells by limiting dilution. At 48 h after inoculation, cells were fixed and stained with anti-GP antibody and foci counted. ( C ) siRNA treated cells were challenged with GFP-EBOV with representative images shown from 48 hpi. Infected cells expressing GFP (green) and nuclei stained with Hoechst 33342 (blue) are visible. Scale bar = 500 µm. ( D ) Count of GFP-positive cells. The numbers of GFP-positive cells and the nuclei in each image were counted by CellProfiler software and infection efficiency was calculated by dividing the number of GFP-positive cells by that of the nuclei. ( E ) CAPG expression in each knockout (KO) and KD clones was detected by immunoblot. β-actin was used as a loading control. WT Hela = parental WT Hela cells and clones are indicated. ( F ) Time-course analysis of virus spread for each clone. At each indicated time point after infection with WT-EBOV, the cells were fixed and stained with anti-GP antibody. The number of GP-positive cells were counted by CellProfiler software, then normalized to that of the nuclei count in the same image. All data are means of three independent experiments +/− SDs. One-way ANOVA with Dunnett’s multiple comparisons test was used for statistical analysis relative to non-targeting siRNA treated control samples or the CRISPR clone control. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
    Rabbit Polyclonal Anti Capg Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti capg antibody/product/Proteintech
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal anti capg antibody - by Bioz Stars, 2026-02
    93/100 stars
      Buy from Supplier

    90
    Sino Biological polyclonal rabbit anti capg antibody
    Suppression of <t>CAPG</t> impairs EBOV infection. ( A ) CAPG knockdown (KD) was confirmed by immunoblot assay. Four siRNA targeting different regions of human CAPG were transfected into Hela cells at 40 nM. After 48 h, cells were challenged with virus and a replicate set were lysed for protein expression analysis by immunoblot (a representative blot is shown). β-actin was used as a loading control. Band intensity from triplicate samples was calculated using ImageJ, and normalized to the β-actin loading control. ( B ) Yield of infectious particles in the supernatant was measured by counting GP positive foci on VeroE6 cells. Cells were inoculated with the supernatant from wild-type EBOV-infected cells by limiting dilution. At 48 h after inoculation, cells were fixed and stained with anti-GP antibody and foci counted. ( C ) siRNA treated cells were challenged with GFP-EBOV with representative images shown from 48 hpi. Infected cells expressing GFP (green) and nuclei stained with Hoechst 33342 (blue) are visible. Scale bar = 500 µm. ( D ) Count of GFP-positive cells. The numbers of GFP-positive cells and the nuclei in each image were counted by CellProfiler software and infection efficiency was calculated by dividing the number of GFP-positive cells by that of the nuclei. ( E ) CAPG expression in each knockout (KO) and KD clones was detected by immunoblot. β-actin was used as a loading control. WT Hela = parental WT Hela cells and clones are indicated. ( F ) Time-course analysis of virus spread for each clone. At each indicated time point after infection with WT-EBOV, the cells were fixed and stained with anti-GP antibody. The number of GP-positive cells were counted by CellProfiler software, then normalized to that of the nuclei count in the same image. All data are means of three independent experiments +/− SDs. One-way ANOVA with Dunnett’s multiple comparisons test was used for statistical analysis relative to non-targeting siRNA treated control samples or the CRISPR clone control. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.
    Polyclonal Rabbit Anti Capg Antibody, supplied by Sino Biological, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/polyclonal rabbit anti capg antibody/product/Sino Biological
    Average 90 stars, based on 1 article reviews
    polyclonal rabbit anti capg antibody - by Bioz Stars, 2026-02
    90/100 stars
      Buy from Supplier

    Image Search Results


    Journal: Cell reports

    Article Title: Integrative multi-omic profiling of adult mouse brain endothelial cells and potential implications in Alzheimer’s disease

    doi: 10.1016/j.celrep.2023.113392

    Figure Lengend Snippet:

    Article Snippet: rabbit anti-CAPG , Proteintech , Cat# 10194-1-AP; RRID: AB_2069179.

    Techniques: Control, Recombinant, Transfection, Isolation, Transgenic Assay, Software

    Suppression of CAPG impairs EBOV infection. ( A ) CAPG knockdown (KD) was confirmed by immunoblot assay. Four siRNA targeting different regions of human CAPG were transfected into Hela cells at 40 nM. After 48 h, cells were challenged with virus and a replicate set were lysed for protein expression analysis by immunoblot (a representative blot is shown). β-actin was used as a loading control. Band intensity from triplicate samples was calculated using ImageJ, and normalized to the β-actin loading control. ( B ) Yield of infectious particles in the supernatant was measured by counting GP positive foci on VeroE6 cells. Cells were inoculated with the supernatant from wild-type EBOV-infected cells by limiting dilution. At 48 h after inoculation, cells were fixed and stained with anti-GP antibody and foci counted. ( C ) siRNA treated cells were challenged with GFP-EBOV with representative images shown from 48 hpi. Infected cells expressing GFP (green) and nuclei stained with Hoechst 33342 (blue) are visible. Scale bar = 500 µm. ( D ) Count of GFP-positive cells. The numbers of GFP-positive cells and the nuclei in each image were counted by CellProfiler software and infection efficiency was calculated by dividing the number of GFP-positive cells by that of the nuclei. ( E ) CAPG expression in each knockout (KO) and KD clones was detected by immunoblot. β-actin was used as a loading control. WT Hela = parental WT Hela cells and clones are indicated. ( F ) Time-course analysis of virus spread for each clone. At each indicated time point after infection with WT-EBOV, the cells were fixed and stained with anti-GP antibody. The number of GP-positive cells were counted by CellProfiler software, then normalized to that of the nuclei count in the same image. All data are means of three independent experiments +/− SDs. One-way ANOVA with Dunnett’s multiple comparisons test was used for statistical analysis relative to non-targeting siRNA treated control samples or the CRISPR clone control. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.

    Journal: Viruses

    Article Title: CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected Cells

    doi: 10.3390/v14091903

    Figure Lengend Snippet: Suppression of CAPG impairs EBOV infection. ( A ) CAPG knockdown (KD) was confirmed by immunoblot assay. Four siRNA targeting different regions of human CAPG were transfected into Hela cells at 40 nM. After 48 h, cells were challenged with virus and a replicate set were lysed for protein expression analysis by immunoblot (a representative blot is shown). β-actin was used as a loading control. Band intensity from triplicate samples was calculated using ImageJ, and normalized to the β-actin loading control. ( B ) Yield of infectious particles in the supernatant was measured by counting GP positive foci on VeroE6 cells. Cells were inoculated with the supernatant from wild-type EBOV-infected cells by limiting dilution. At 48 h after inoculation, cells were fixed and stained with anti-GP antibody and foci counted. ( C ) siRNA treated cells were challenged with GFP-EBOV with representative images shown from 48 hpi. Infected cells expressing GFP (green) and nuclei stained with Hoechst 33342 (blue) are visible. Scale bar = 500 µm. ( D ) Count of GFP-positive cells. The numbers of GFP-positive cells and the nuclei in each image were counted by CellProfiler software and infection efficiency was calculated by dividing the number of GFP-positive cells by that of the nuclei. ( E ) CAPG expression in each knockout (KO) and KD clones was detected by immunoblot. β-actin was used as a loading control. WT Hela = parental WT Hela cells and clones are indicated. ( F ) Time-course analysis of virus spread for each clone. At each indicated time point after infection with WT-EBOV, the cells were fixed and stained with anti-GP antibody. The number of GP-positive cells were counted by CellProfiler software, then normalized to that of the nuclei count in the same image. All data are means of three independent experiments +/− SDs. One-way ANOVA with Dunnett’s multiple comparisons test was used for statistical analysis relative to non-targeting siRNA treated control samples or the CRISPR clone control. *, p < 0.05; **, p < 0.01; ***, p < 0.001; ****, p < 0.0001.

    Article Snippet: Rabbit polyclonal anti-CAPG antibody (10194-1-AP) was from Proteintech (Rosemont, IL, USA).

    Techniques: Infection, Knockdown, Western Blot, Transfection, Virus, Expressing, Control, Staining, Software, Knock-Out, Clone Assay, CRISPR

    Effect of CAPG suppression on EBOV uptake into cells. ( A ) Hela cells were treated with siRNA for 48 h, incubated with WT-EBOV at 14 °C for 1 h to allow binding without uptake and then temperature raised 37 °C to obtain synchronized virus uptake. Cells were then fixed and stained with anti-GP and Alexa Flour 594 antibody (red). Subsequently, cells were permeabilized with 0.2% Triton X-100 detergent and restained with anti-GP and Alexa Fluor 488 antibody (green). CellMask Blue was used for staining both the cell cytoplasm and nucleus (blue). Arrowheads show double stained puncta (uninternalized virus on the cell surface). Scale bars = 5 µm. Images below are magnified images indicated by dotted lines in areas where fluorescent green stained (internalized) virus particles are evident. The percentage of internalized virus was calculated as the ratio of green foci to total foci and shown in the graph below the images. ( B ) RT-qPCR detection of viral RNA during early infection. siRNA-treated Hela cells were incubated with WT-EBOV for 1 h, then the cells were washed and fresh medium was added onto the cells. The cells were lysed at 4 hpi for RNA extraction. Viral RNA was detected using a primer and probe set targeting NP gene (see . ΔΔCq was calculated using GAPDH as a reference control in each sample. The data are shown as fold change relative to siRNA non-targeting control. A 1 h pre-treatment with 50 µM of the amiloride, EIPA, or chlorpromazine (CPZ) were used as macropinocytosis and clathrin-dependent endocytosis inhibitors, respectively. One-way ANOVA with Dunnett’s multiple comparisons test was used for statistical analysis relative to control samples. The means of at least 2 independent experiments are shown ± SD. **, p < 0.01.

    Journal: Viruses

    Article Title: CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected Cells

    doi: 10.3390/v14091903

    Figure Lengend Snippet: Effect of CAPG suppression on EBOV uptake into cells. ( A ) Hela cells were treated with siRNA for 48 h, incubated with WT-EBOV at 14 °C for 1 h to allow binding without uptake and then temperature raised 37 °C to obtain synchronized virus uptake. Cells were then fixed and stained with anti-GP and Alexa Flour 594 antibody (red). Subsequently, cells were permeabilized with 0.2% Triton X-100 detergent and restained with anti-GP and Alexa Fluor 488 antibody (green). CellMask Blue was used for staining both the cell cytoplasm and nucleus (blue). Arrowheads show double stained puncta (uninternalized virus on the cell surface). Scale bars = 5 µm. Images below are magnified images indicated by dotted lines in areas where fluorescent green stained (internalized) virus particles are evident. The percentage of internalized virus was calculated as the ratio of green foci to total foci and shown in the graph below the images. ( B ) RT-qPCR detection of viral RNA during early infection. siRNA-treated Hela cells were incubated with WT-EBOV for 1 h, then the cells were washed and fresh medium was added onto the cells. The cells were lysed at 4 hpi for RNA extraction. Viral RNA was detected using a primer and probe set targeting NP gene (see . ΔΔCq was calculated using GAPDH as a reference control in each sample. The data are shown as fold change relative to siRNA non-targeting control. A 1 h pre-treatment with 50 µM of the amiloride, EIPA, or chlorpromazine (CPZ) were used as macropinocytosis and clathrin-dependent endocytosis inhibitors, respectively. One-way ANOVA with Dunnett’s multiple comparisons test was used for statistical analysis relative to control samples. The means of at least 2 independent experiments are shown ± SD. **, p < 0.01.

    Article Snippet: Rabbit polyclonal anti-CAPG antibody (10194-1-AP) was from Proteintech (Rosemont, IL, USA).

    Techniques: Incubation, Binding Assay, Virus, Staining, Quantitative RT-PCR, Infection, RNA Extraction, Control

    Effect of CAPG suppression on EBOV release from cells. ( A ) Measurement of the quantity of viral RNA released from siRNA treated cells. At 48 hpi, RNA was extracted from the supernatant (sup) and the remaining cells (cell lysate), then virus RNA levels measured by RT-qPCR using primers for NP. The graph indicates Cq supernatant-cell lysate signals in each sample relative to the siRNA control. ( B ) The efficiency of VLP formation from cells treated with each indicated siRNA. Hela cells seeded in a 6 well plate were transduced with siRNA (40 nM each) and pCAGGS-Ebola VP40 plasmid (0.5 µg). At 48 h post transfection, the supernatant was collected and centrifuged to remove cell debris. VLPs were collected by pelleting through a 20% sucrose cushion. VLP pellets and cell lysates were analyzed by immunoblot. Band intensity from each sample is shown relative to siRNA non-targeting control. All assays were repeated at least twice and the representative data sets are shown. One-way ANOVA with Dunnett’s multiple comparisons test was used for statistical analysis relative to control samples. One-way ANOVA with Dunnett’s multiple comparisons test was used for statistical analysis relative to control samples. The means at least two independent experiments ± SDs are shown. **, p < 0.01; ****, p < 0.0001.

    Journal: Viruses

    Article Title: CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected Cells

    doi: 10.3390/v14091903

    Figure Lengend Snippet: Effect of CAPG suppression on EBOV release from cells. ( A ) Measurement of the quantity of viral RNA released from siRNA treated cells. At 48 hpi, RNA was extracted from the supernatant (sup) and the remaining cells (cell lysate), then virus RNA levels measured by RT-qPCR using primers for NP. The graph indicates Cq supernatant-cell lysate signals in each sample relative to the siRNA control. ( B ) The efficiency of VLP formation from cells treated with each indicated siRNA. Hela cells seeded in a 6 well plate were transduced with siRNA (40 nM each) and pCAGGS-Ebola VP40 plasmid (0.5 µg). At 48 h post transfection, the supernatant was collected and centrifuged to remove cell debris. VLPs were collected by pelleting through a 20% sucrose cushion. VLP pellets and cell lysates were analyzed by immunoblot. Band intensity from each sample is shown relative to siRNA non-targeting control. All assays were repeated at least twice and the representative data sets are shown. One-way ANOVA with Dunnett’s multiple comparisons test was used for statistical analysis relative to control samples. One-way ANOVA with Dunnett’s multiple comparisons test was used for statistical analysis relative to control samples. The means at least two independent experiments ± SDs are shown. **, p < 0.01; ****, p < 0.0001.

    Article Snippet: Rabbit polyclonal anti-CAPG antibody (10194-1-AP) was from Proteintech (Rosemont, IL, USA).

    Techniques: Virus, Quantitative RT-PCR, Control, Transduction, Plasmid Preparation, Transfection, Western Blot

    EBOV proteins localize in close proximity to CAPG in the cell cytoplasm. ( A ) Proximity ligation assays were used to detect CAPG and viral protein association. Hela cells were infected with WT-EBOV for 24 h, then fixed and permeabilized. Cells were treated with the indicated antibodies specific for each native protein and detected protein complexes stained red. Cell nuclei were stained with Hoechst 33342 (blue). The lower set of images from infected cells are magnified from the indicated sections of images (dotted squares). Scale bars = 50 µm, and 10 µm in magnified images. ( B ) A representative image (left) of amplified signal (red) of VP40-CAPG and phalloidin (green). The images were taken from the middle z-plane from an image stack. A magnified image (right) is shown for a region indicated by the dotted square. Arrowheads indicate sites where CAPG-VP40 complexes and phalloidin staining (F-actin) overlap. Scale bar = 10 µm and 2 µm in the magnified images.

    Journal: Viruses

    Article Title: CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected Cells

    doi: 10.3390/v14091903

    Figure Lengend Snippet: EBOV proteins localize in close proximity to CAPG in the cell cytoplasm. ( A ) Proximity ligation assays were used to detect CAPG and viral protein association. Hela cells were infected with WT-EBOV for 24 h, then fixed and permeabilized. Cells were treated with the indicated antibodies specific for each native protein and detected protein complexes stained red. Cell nuclei were stained with Hoechst 33342 (blue). The lower set of images from infected cells are magnified from the indicated sections of images (dotted squares). Scale bars = 50 µm, and 10 µm in magnified images. ( B ) A representative image (left) of amplified signal (red) of VP40-CAPG and phalloidin (green). The images were taken from the middle z-plane from an image stack. A magnified image (right) is shown for a region indicated by the dotted square. Arrowheads indicate sites where CAPG-VP40 complexes and phalloidin staining (F-actin) overlap. Scale bar = 10 µm and 2 µm in the magnified images.

    Article Snippet: Rabbit polyclonal anti-CAPG antibody (10194-1-AP) was from Proteintech (Rosemont, IL, USA).

    Techniques: Ligation, Infection, Staining, Amplification

    Identification of CAPG subdomains important for interaction with VP40. ( A ) Schematic representation of the CAPG protein. Each gelsolin domain is indicated by S1, S2 and S3. The 3D structure of CAPG is shown and was derived from PDB 1JHW. ( B ) Shows the arrangement of the tripartite split GFP system. For this assay, the GFP10 peptide was used to tag VP40 and the GFP11 peptide was used for the indicated host cell protein targets. When each part is brought together with the remainder, GFP1-9, cells fluoresce green through formation of mature GFP. ( C ) Representative images showing cell nuclei stained with Hoechst 33342 (blue) and GFP positive cells (green), representing reconstituted GFP, for the indicated host protein tagged to GFP11 peptide and VP40 tagged to the GFP10 peptide. ( D ) Quantitation of image sets for N-terminus tagged proteins with GFP11. Sets of 4 wells were transfected with each tagged construct and GFP1-9 expression plasmid that also encoded mCherry as a marker of transfection efficiency. The number of GFP-expressing cells was counted using CellProfiler and expressed as the fraction of transfected cells. ( E ) Quantitation of image sets for C-terminus tagged domains. The S3 domain of CAPG was expressed as a C-terminal fusion with GFP11. Despite lower efficiency of mature GFP formation, significant activity allowed comparison to full length CAPG. Mean ± SD are shown with *, p < 0.05; ***, p < 0.001; ****, p < 0.0001 by One-way ANOVA with Dunnet’s multiple comparisons test.

    Journal: Viruses

    Article Title: CAPG Is Required for Ebola Virus Infection by Controlling Virus Egress from Infected Cells

    doi: 10.3390/v14091903

    Figure Lengend Snippet: Identification of CAPG subdomains important for interaction with VP40. ( A ) Schematic representation of the CAPG protein. Each gelsolin domain is indicated by S1, S2 and S3. The 3D structure of CAPG is shown and was derived from PDB 1JHW. ( B ) Shows the arrangement of the tripartite split GFP system. For this assay, the GFP10 peptide was used to tag VP40 and the GFP11 peptide was used for the indicated host cell protein targets. When each part is brought together with the remainder, GFP1-9, cells fluoresce green through formation of mature GFP. ( C ) Representative images showing cell nuclei stained with Hoechst 33342 (blue) and GFP positive cells (green), representing reconstituted GFP, for the indicated host protein tagged to GFP11 peptide and VP40 tagged to the GFP10 peptide. ( D ) Quantitation of image sets for N-terminus tagged proteins with GFP11. Sets of 4 wells were transfected with each tagged construct and GFP1-9 expression plasmid that also encoded mCherry as a marker of transfection efficiency. The number of GFP-expressing cells was counted using CellProfiler and expressed as the fraction of transfected cells. ( E ) Quantitation of image sets for C-terminus tagged domains. The S3 domain of CAPG was expressed as a C-terminal fusion with GFP11. Despite lower efficiency of mature GFP formation, significant activity allowed comparison to full length CAPG. Mean ± SD are shown with *, p < 0.05; ***, p < 0.001; ****, p < 0.0001 by One-way ANOVA with Dunnet’s multiple comparisons test.

    Article Snippet: Rabbit polyclonal anti-CAPG antibody (10194-1-AP) was from Proteintech (Rosemont, IL, USA).

    Techniques: Derivative Assay, Staining, Quantitation Assay, Transfection, Construct, Expressing, Plasmid Preparation, Marker, Activity Assay, Comparison